Recruiting studies: Diabetic Kidney Disease Dkd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
Phase 2 · 20 location(s) · Aptabio Therapeutics, Inc. · NCT06962098 Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidn
Phase 2 · 57 location(s) · Regeneron Pharmaceuticals · NCT07271186 Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy
Phase N/A · 1 location(s) · Chinese PLA General Hospital · NCT03865914 A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
Phase 1 · 1 location(s) · Alebund Pharmaceuticals · NCT06666283 Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
Phase 1 · 1 location(s) · Mediar Therapeutics · NCT07473323 Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)
Phase 2 · 1 location(s) · Shinshu University · NCT05469659 A Long-Term Follow-Up Study of Participants Exposed to REACT
Phase N/A · 1 location(s) · Prokidney · NCT05918523 Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease
Phase 2 · 6 location(s) · Chinese PLA General Hospital · NCT06969807

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.